• Choice of the doctor: is an alternative hormonal therapy?
To content

Choice of the doctor: is an alternative hormonal therapy?

HEALTH OF WOMAN. 2018.1(127):28–32; doi 10.15574/HW.2018.127.28

A.V. Prokopyuk
Kharkiv medical Academy of postgraduate education

The breast pathology is associated with a female sex hormones failure. It can cause estrogen-dependent cancers. The problem of the mastopathy and mastodynia (fibrocystic breast disease, benign mammary dysplasia) therapy is not completely solved. The hormone therapy is associated with complications and has a large number of contraindications, which makes finding new strategies for the prevention and treatment of these diseases.
The aim of the study was to compare the effects of hormonal and non-hormonal drugs. Combined application of capsules and cream Mammodol® in women with mastopathy and mastodynia leads to pronounced clinical, ultrasound and laboratory effects. This allows to recommend it as an alternative to hormone therapy.
Key words: mastopathy, benign mammary dysplasia, estrogens, psychoemotional state, indole-3-carbinol, Vitex Agnus castus, hormone therapy, joint application, prolactin.

REFERENCES

1. Astahov VM. 2011. Negormonalnaya patogeneticheski obosnovannaya terapiya miomyi matki. Zh.Zdorove Zhenschinyi 3(59):4–6.

2. Labyigina AV, Suturina LV, Leschenko OYa i dr. 2006. Izmeneniya prolaktina na fone priema oralnyih kontratseptivov u devushek s funktsionalnoy giperprolaktinemiey. Byulleten VSNTs SO RAMN. 1(47):79.

3. Diagnostika i lechenie giperprolaktinemii: klinicheskie rekomendatsii mezhdunarodnogo endokrinologicheskogo obschestva i vzglyad rossiyskih ekspertov, d m n, prof. LK Dzeranova, k m n IA Ilovayskaya FGBU «Endokrinologicheskiy nauchnyiy tsentr», Moskva 2 GU «MONIKI im. MF Vladimirskogo», Moskva EF. Akusherstvo, ginekologiya 1:155. 2012.

4. Kiselev VI, Lyashenko AA. 2005. Indinol – regulyator proliferativnyih protsessov v organah reproduktivnoy sistemyi. M:56.

5. Kuzmina IYu. 2012. Sovremennyie podhodyi k terapii giperplazii endometriya u zhenschin perimenopauzalnogo perioda. Tavricheskiy mediko-biologicheskiy vestnik 15;2;1(58):56–59.

6. Lutsenko NS, Geraskina LR, Evtereva IA i dr. 2009. Nekotoryie mehanizmyi aktivatsii proliferativnyih protsessov v organah reproduktivnoy sistemyi. Mediko-sotsIalnI problemi sIm’Yi 14;4:134–139.

7. Mkrtchan NS. 2005. Ultrazvukovaya diagnostika v otsenke effektivnosti lecheniya mastopatii. Diss. kand. med. nauk. Moskva:18.

8. Nikonov VV. 2005. Sistemnyiy otvet organizma na agressiyu. Novosti meditsinyi i farmatsii 16:3–5.

9. Prilepskaya VN, Volobuev AI, Shvetsova OB. 2003. Mastalgiya u zhenschin reproduktivnogo vozrasta: klinika, diagnostika, lechenie. Ginekologiya 5;4:4–11.

10. Uvarova EV, Boldyireva NV. 2007. Vozmozhnosti negormonalnoy korrektsii urovnya prolaktina na fone gormonalnoy kontratseptsii u seksualno aktivnyih molodyih zhenschin. «RMZh» 3:191.

11. Cerqueira RO, Frey BN, Leclerc E, Brietzke E. 2017, Dec. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health 20(6):713-719. https://doi.org/10.1007/s00737-017-0791-0. Epub 2017 Oct 23. Review.

12. Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL. 2016, Oct. Botanicals and Their Bioactive Phytochemicals for Women’s Health. Pharmacol Rev. 68(4):1026-1073. Review. https://doi.org/10.1124/pr.115.010843; PMid:27677719 PMCid:PMC5050441

13. Gaston-Johansson F, Albert M, Fagan E, Zimmerman L. 1990, Apr. Similarities in pain descriptions of four different ethnic-culture groups. J Pain Symptom Manage. 5(2):94–100. https://doi.org/10.1016/S0885-3924(05)80022-3

14. Licznerska B, Baer-Dubowska W. 2016. Indole-3-Carbinol and Its Role in Chronic Diseases. Adv Exp Med Biol. 928:131–154. https://doi.org/10.1007/978-3-319-41334-1_6; PMid:27671815

15. Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD. 2016, Jul. Indole-3-carbinol induces tumor cell death: function follows form. J Surg Res. 204(1):47-54. https://doi.org/10.1016/j.jss.2016.04.021. Epub 2016 Apr 22. Review.

16. Rafieian-Kopaei M, Movahedi M. 2017, Jan 25. Systematic Review of Premenstrual, Postmenstrual and Infertility Disorders of Vitex Agnus Castus. Electron Physician 9(1): 3685-3689. https://doi.org/10.19082/3685. eCollection 2017 Jan. Review.

17. Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, Higginbotham SM, Cavalieri EL. 2003, Apr. Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis (England). 24(4):697–702. https://doi.org/10.1093/carcin/bgg004

18. Utsunomiya H, Ito K, Suzuki T, Kitamura T, Kaneko C, Nakata T, Niikura H, Okamura K, Yaegashi N, Sasano H. 2004, Sep 1. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Clin Cancer Res. 10(17):5850–5656. https://doi.org/10.1158/1078-0432.CCR-04-0040; PMid:15355916

19. Verkaik S, Kamperman AM, van Westrhenen R, Schulte PFJ. 2017, Aug. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 217(2):150-166. doi: 10.1016/j.ajog. 2017.02.028. Epub 2017 Feb 22. Review.

20. Wang Q, Li X, Wang L, Feng YH, Zeng R, Gorodeski G. 2004. Antiapoptotic effects of estrogen in normal and cancer human cervical epithelial cells. Endocrinology 145(12):5568–5579. https://doi.org/10.1210/en.2004-0807; PMid:15319352

21. Lasachko SA. 2016. Otsenka effektivnosti primeneniya preparata Indol-F u patsientok reproduktivnogo vozrasta s displaziey molochnyih zhelez. Meditsinskie aspektyi zdorovya zhenschinyi 7:25–31.

22. Instruktsiya proizvoditelya na krem Mammodol®.